Trademark: 88693707
Word

Status
Registered
Status Code
700
Status Date
Tuesday, June 22, 2021
Serial Number
88693707
Registration Number
6392382
Registration Date
Tuesday, June 22, 2021
Mark Type
2
Filing Date
Friday, November 15, 2019
Published for Opposition
Tuesday, April 6, 2021

Trademark Owner History

Classifications
5 pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of cardiovascular disorders, allergies, anaphylaxis, central nervous system disorders, peripheral nervous system disorders, reproductive health disorders, electrolytic imbalance, caloric imbalance, obesity, nutritional disorders, autoimmune disorders, endocrine disorders, gastrointestinal disorders, inflammatory disorders, dermatological disorders, infectious diseases, hormonal imbalance, pain, complications arising from organ transplantation, cancer, pulmonary disorders, renal disorders, urinary system disorders, ophthalmic disorders, otic disorders, sense organ disorders, dental disorders, musculoskeletal disorders, diabetic disorders, neuromuscular disorders, bone disorders, blood disorders, metabolic disorders, psychosis; pharmaceutical drugs, preparations and medications for use in sedation, analgesia, anaesthesia; pharmaceutical drugs, preparations and medications for use in the prevention, reduction and treatment of senile disorders, sleep disorders, dementia, congenital disease disorders, abnormal gene disorders, hair growth disorders, gynaecological diseases, obstetric disorders, withdrawal syndromes, hormonal disorders, urogenital organ disorders, sexual dysfunction, nausea and vomiting, emesis, migraine, edema, multiple sclerosis, chronic obstructive pulmonary disorder, depression, pregnancy, spasms, hypertension, hypotension, angioedema, fungal diseases, fertility disorders, hyperglycemia, hypoglycemia, post-operative disorders, arthritis, psoriasis and localized fat deposits; pharmaceutical and biological preparations for use in diagnosis, namely, for use as and X-ray contrast reagents
The mark consists of a stylized design of a molecule with eight large circles and four small circles connected with straight lines and eight small circles positioned around it.
Color is not claimed as a feature of the mark.

Trademark Events
Nov 19, 2019
New Application Entered
Feb 20, 2020
Assigned To Examiner
Feb 21, 2020
Non-Final Action Written
Nov 21, 2019
New Application Office Supplied Data Entered
Nov 22, 2019
Notice Of Design Search Code E-Mailed
Feb 21, 2020
Non-Final Action E-Mailed
Feb 21, 2020
Notification Of Non-Final Action E-Mailed
Aug 18, 2020
Teas Response To Office Action Received
Aug 18, 2020
Correspondence Received In Law Office
Aug 18, 2020
Teas/Email Correspondence Entered
Sep 9, 2020
Final Refusal Written
Sep 9, 2020
Final Refusal E-Mailed
Sep 9, 2020
Notification Of Final Refusal Emailed
Feb 8, 2021
Teas Request For Reconsideration Received
Feb 8, 2021
Correspondence Received In Law Office
Feb 8, 2021
Teas/Email Correspondence Entered
Mar 1, 2021
Approved For Pub - Principal Register
Mar 17, 2021
Notification Of Notice Of Publication E-Mailed
Apr 6, 2021
Published For Opposition
Apr 6, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 22, 2021
Registered-Principal Register
Jul 16, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 16, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 16, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 16, 2024
Teas Change Of Correspondence Received
Jul 16, 2024
Teas Change Of Owner Address Received

Trademark Alertz updated from USPTO on 2030-01-24